The saliva-based test identifies mutations in the BRCA1 and BRCA2 genes with 99.99 percent accuracy.
The institute will work with Kailos Genetics to provide free mutation testing for BRCA1/2 and 17 other genes linked to greater risk of breast and ovarian cancer.
Through its agreement with Quest Diagnostics, the company plans to launch a BRCA1/2 test, followed by tests for Lynch syndrome and HPV.
Although male breast cancer is uncommon, and in the past men haven't been readily tested for inherited risk mutations, more men are speaking out about their experiences.
For every paid myBRCA test performed, the startup said that it will donate a free test.
Data presented at the meeting helped better define the potential benefits and risks of broad panel-based tests for hereditary cancer genes.
Opko plans to leverage BRL's national marketing, sales, and distribution resources to enhance the sale of its blood-based 4Kscore test for aggressive prostate cancer.
The company has established a streamlined workflow that customizes and automates key steps of the sample prep process.
In joining forces to support BRCAShare, Quest and LabCorp are taking on Myriad Genetics, which maintains a proprietary database with more than 1 million test results.
The company offers a panel that analyzes 19 genes associated with breast and ovarian cancer, including BRCA1/2, for $249.
Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.
Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.
In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.
Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.